| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |